Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Osaki

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Oncology|October 18, 2001
Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancerR Kim, A Osaki, J Kojima, et al.
Breast Cancer Research and Treatment|January 1, 1994
Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical studyM Toi, T Tominaga, A Osaki, et al.
The Journal of Biological Chemistry|November 10, 1984
Proteolysis in eukaryotic cells. Proteinase yscE, a new yeast peptidaseT Achstetter, C Ehmann, A Osaki, et al.
Oncology Reports|April 11, 2001
A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor actionR Kim, A Osaki, K Tanabe, et al.
Anticancer Research|January 29, 2000
The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patientsT Hirai, M Kuwahara, K Yoshida, et al.
American Journal of Surgery|October 1, 1992
Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patientsA Osaki, M Toi, H Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1991
[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients]A Osaki, M Toi, H Yamada, et al.
Archives of Neurology|September 17, 1999
Coagulation activation in patients with Binswanger diseaseH Tomimoto, I Akiguchi, H Wakita, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|September 1, 1990
[The expression of NCC-ST-439, a tumor marker, in human breast cancer patients]E Miyahara, M Toi, T Wada, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2001
An analysis of relapsed breast cancer in patients previously treated with breast conserving surgeryR Kim, N Nishimoto, A Osaki, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Oncology|October 18, 2001
Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancerR Kim, A Osaki, J Kojima, et al.
Breast Cancer Research and Treatment|January 1, 1994
Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical studyM Toi, T Tominaga, A Osaki, et al.
The Journal of Biological Chemistry|November 10, 1984
Proteolysis in eukaryotic cells. Proteinase yscE, a new yeast peptidaseT Achstetter, C Ehmann, A Osaki, et al.
Oncology Reports|April 11, 2001
A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor actionR Kim, A Osaki, K Tanabe, et al.
Anticancer Research|January 29, 2000
The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patientsT Hirai, M Kuwahara, K Yoshida, et al.
American Journal of Surgery|October 1, 1992
Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patientsA Osaki, M Toi, H Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1991
[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients]A Osaki, M Toi, H Yamada, et al.
Archives of Neurology|September 17, 1999
Coagulation activation in patients with Binswanger diseaseH Tomimoto, I Akiguchi, H Wakita, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|September 1, 1990
[The expression of NCC-ST-439, a tumor marker, in human breast cancer patients]E Miyahara, M Toi, T Wada, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2001
An analysis of relapsed breast cancer in patients previously treated with breast conserving surgeryR Kim, N Nishimoto, A Osaki, et al.
Pageof 3